Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the …
Biotechnology
US, Waltham [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Syndax Pharmaceuticals, Inc. has no acquisition track records yet.
M&A Deals · History
Syndax Pharmaceuticals, Inc. has no acquisition track records yet.